Qube Research & Technologies (QRT)
ACET icon

Qube Research & Technologies (QRT)’s Adicet Bio ACET Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,266
Closed -$16.4K – 3637
2025
Q3 		$16.4K Buy
1,266
+19
+2% +$224 ﹤0.01% 3304
2025
Q2 		$12.2K Sell
1,247
-2,118
-63% -$22.3K ﹤0.01% 3304
2025
Q1 		$40.6K Sell
3,365
-5,142
-60% -$73.5K ﹤0.01% 3149
2024
Q4 		$131K Buy
8,507
+323
+4% +$6.1K ﹤0.01% 2934
2024
Q3 		$189K Sell
8,184
-7,401
-47% -$166K ﹤0.01% 2608
2024
Q2 		$302K Buy
15,585
+8,757
+128% +$235K ﹤0.01% 2304
2024
Q1 		$257K Buy
+6,828
New +$282K ﹤0.01% 2902
2023
Q2 		– Sell
-843
Closed -$77.7K – 2340
2023
Q1 		$77.7K Sell
843
-7,245
-90% -$909K ﹤0.01% 2171
2022
Q4 		$1.16M Buy
+8,088
New +$2.02M 0.01% 1157
2021
Q2 		– Sell
-848
Closed -$177K – 2202
2021
Q1 		$177K Sell
848
-1,522
-64% -$349K ﹤0.01% 1675
2020
Q4 		$533K Buy
+2,370
New +$485K 0.01% 1096
2020
Q3 		– Sell
-127
Closed -$31K – 1615
2020
Q2 		$31K Buy
+127
New +$25K ﹤0.01% 1644

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACET Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 1,266 shares — an estimated $16.4K sold.

Qube Research & Technologies (QRT) first reported a position in ACET in Q2 2020 and held it in 12 quarters. The position peaked at $1.16M in Q4 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,266 Adicet Bio shares in Q4 2025, an estimated $16.4K.
  • Qube Research & Technologies (QRT) first reported a position in Adicet Bio in Q2 2020 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s Adicet Bio position peaked at $1.16M in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.